The Department of Commerce and the Department of State recently announced that they were following through with changes to treat Hong Kong like China for exports of military and dual-use goods. The impetus for these measures was China's proposal to pass a controversial national security law affecting Hong Kong, which Beijing's top legislative body finally passed on 30 June 2020.
The Organisation for Economic Cooperation and Development's Inclusive Framework aims to reach an agreement on a multilateral taxation framework for the digitised economy by the end of 2020. However, US Trade Representative Robert Lighthizer recently confirmed that the United States has withdrawn its participation from the digital tax talks. The United States' withdrawal is a step towards new tariffs on imports from countries that apply their own digital services tax.
In four new FAQs, the Office of Foreign Assets Control has provided a few surprises in its clarifications of the sector-based sanctions contained in Iran-Related Executive Order (EO) 13902. The new FAQs confirm earlier guidance and provide detailed but mostly unremarkable definitions of the four sectors of the Iranian economy, as well as the goods and services used in connection with those sectors, that are targeted by EO 13902 and the meanings of the terms 'knowingly' and 'significant'.
The Department of Commerce and the Bureau of Industry and Security recently revised an arcane export control rule that imposes US export controls on foreign-origin products that are a direct product of certain US technologies. Although the two new categories of foreign direct product are far broader than the old one, new foreign direct products require a licence only when they are exported or re-exported to entities on a new special subset of the Entity List, which includes Huawei, HiSilicon and other Huawei affiliates.
A new executive order has formalised Team Telecom, a previously ad hoc committee which for many years has reviewed applications for Federal Communications Commission (FCC) authorisations involving non-US parties, typically for US-international telecoms service or submarine cable landings. The committee has the primary responsibility of reviewing applications for FCC authorisations which involve foreign ownership to identify national security or law enforcement risks.
Through an array of legislative and administrative measures, the government has made significant strides in recent years to limit, and perhaps end altogether, the proliferation of Chinese-origin telecoms technology in US infrastructure. While some of the legislation is company agnostic, Chinese telecoms giant Huawei, which remains on the Department of Commerce, Bureau of Industry and Security's Entity List, is a primary target.
Recognising that COVID-19 is further straining humanitarian needs in sanctioned countries and complicating compliance with economic sanctions, the Department of the Treasury Office of Foreign Assets Control recently issued web-based guidance to remind the public of the many ways in which medical exports and other humanitarian services, supplies and donations can legally flow to sanctioned countries, offer reporting and compliance flexibility and provide some Iran secondary sanctions relief.
The Commerce Department recently took significant steps to revise the Export Administration Regulations to address military-civil fusion. Specifically, the Bureau of Industry and Security issued two final rules regarding licence exception civil end users and military end-use and end-user controls, as well as a proposed rule which would eliminate a provision of the licence exception additional permissive re-exports that currently authorises certain re-exports to China and other countries.
US Customs and Border Protection (CBP) recently released the long-awaited United States-Mexico-Canada Agreement (USMCA) Interim Implementing Instructions, which signal the transition from the North American Free Trade Agreement to the USMCA. For companies operating in the United States, selling into the United States or buying from the US marketplace, these instructions should be viewed as an indication that the USMCA is on track for a possible Summer 2020 entry into force.
Like many other US government agencies, the State Department, Directorate of Defence Trade Controls (DDTC) has announced certain measures, effective immediately, to alleviate burdens caused by COVID-19 in relation to compliance with the International Traffic in Arms Regulations. The changes affect registration, compliance, licensing and outreach to the DDTC.
Effective 20 April 2020, the government has introduced a temporary 90-day postponement of certain import payment deadlines for companies and individuals experiencing significant financial hardship due to the economic fallout from the COVID-19 pandemic. This announcement follows a previously abandoned US Customs and Border Protection action to provide relief, intense lobbying on both sides of the issue and mixed signals from the Trump administration.
In a notification of exemptions action recently published for public inspection, the Federal Emergency Management Agency (FEMA) set out a list of exemptions to its requirement for prior approval to export previously identified scarce medical personal protective equipment. However, despite its attempt to clarify previous rules and guidance, FEMA's notice has raised nearly as many questions as it answers.
The Federal Emergency Management Agency has exercised its delegated authority under the Defence Production Act to issue a temporary final rule (Prioritisation and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use) to prohibit the export of five types of medical personal protective equipment that the government previously identified as scarce and threatened materials during the COVID-19 pandemic.
In this video, International Trade Partners Kay C Georgi and Marwa M Hassoun explain how the Federal Emergency Management Agency's new rule restricting the export of face masks, respirators and other medical personal protective equipment works, as well as how to get a licence and what the penalties are.
In response to the COVID-19 crisis, the US Food and Drug Administration has expanded its Enforcement Discretion Policy for the import, distribution and use of certain masks and other personal protective equipment (PPE) intended for medical use. In addition, US Customs and Border Protection has updated some previous guidance for importing PPE and other medical devices during the pandemic.
To facilitate the import of personal protective equipment and other medical supplies in response to the COVID-19 pandemic, the government continues to waive some tariffs, but balks at broad relief. Among the recent developments in this respect are the launch of a new US Customs and Border Protection (CBP) COVID-19 website. In addition, CBP and the Food and Drug Administration have issued updated guidance for importing COVID-19 supplies and new Section 301 tariff exclusions have been published.
The Defence Production Act (DPA) allows the president to shape the domestic industrial base for national defence preparedness, which includes emergency preparedness activities. This article addresses a number of DPA-related questions that have arisen in light of the COVID-19 pandemic, including how the administration has used the DPA in response to the crisis, what the impact of the administration's DPA-related orders and memoranda will be and what this means for exporters.
As individuals and businesses face the growing health and economic crisis stemming from the global COVID-19 outbreak, the government has searched for balanced ways to provide relief to those struggling, and trade measures are no exception. However, after initially accepting requests from importers in light of the COVID-19 pandemic to defer payment of duties, US Customs and Border Protection recently issued guidance withdrawing this option.
Due to the COVID-19 pandemic, medical items such as masks, ventilators and gowns are difficult to find. With people looking overseas to source these items, this article provides some basic guidance for importing them in a way which satisfies US import requirements and facilitates quick processing through clearance. Many of these items are regulated by the Food and Drug Administration as medical devices and are also subject to US Customs and Border Protection regulations.
The US Trade Representative recently requested comments on the removal of Section 301 tariffs from Chinese medical care, including those that have previously been denied an exclusion, which are needed to respond to the COVID-19 outbreak. As manufacturers of medical care products increase production and unrelated supply chains shift to aid the global fight against COVID-19, parties should consider whether Section 301 tariffs are impeding their ability to contribute to the cause.